Bir sonraki

Otomatik oynatma

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Görünümler • 07/14/23
Pay
gömmek
administrator
administrator
Aboneler
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma